期刊文献+

融合PE38的抗CD70纳米抗体免疫毒素的制备及其对肾透明细胞癌786-O细胞的杀伤作用

Preparetion of anti-CD70 nanobody immunotoxin fused with PE38 and its killing effect on renal clear cell carcinoma 786-O cells
在线阅读 下载PDF
导出
摘要 目的:构建靶向CD70分子的重组免疫毒素,通过表达、纯化制备PE38与抗CD70纳米抗体重组蛋白,体外抗肿瘤实验探究重组蛋白是否对高表达CD70分子的阳性肿瘤细胞具有杀伤活性。方法:通过基因工程手段,将CD70纳米抗体Nb 2B3基因片段通过一个连接子与pET21a-PE38基因片段相连,获得重组表达载体pET21a-Nb 2B3-PE38并转入BL21(DE3)感受态细胞中进行表达、纯化与鉴定。用间接ELISA及FACS法检测Nb 2B3-PE38与CD70分子的结合活性,MTT法检测Nb 2B3-PE38对高表达CD70分子的肾透明细胞癌786-O细胞的体外杀伤活性,AnnexinⅤ-FITC/PI双染法检测Nb 2B3-PE38对786-O细胞凋亡的影响。结果:成功构建抗CD70纳米抗体重组免疫毒素Nb 2B3-PE38,纯化获得纯度>90%的重组蛋白,SDS-PAGE及WB检测结果表明目的蛋白正确表达,分子量为56000。纯化后的Nb 2B3-PE38能与重组CD70抗原及786-O细胞表面的CD70分子特异性结合;25μg/mL Nb 2B3-PE38即对786-O细胞产生极显著的杀伤作用(P<0.001),并且促进786-O细胞的细胞凋亡(P<0.01),其杀伤效应强于阳性对照顺铂(P<0.01)。结论:成功制备了特异性靶向CD70分子的免疫毒素Nb 2B3-PE38,其能够有效杀伤786-O细胞并诱导细胞凋亡且效果强于顺铂。 Objective:To construct a recombinant immunotoxin targeting CD70 molecule,prepare PE38 and anti-CD70 nanobody recombinant proteins by expression and purification,and explore whether the recombinant proteins have killing activity on positive tumor cells with high expression of CD70 molecule through in vitro anti-tumor experiments.Methods:The CD70 nanobody Nb 2B3 gene fragment was ligated with the pET21a-PE38 gene fragment through a linker by genetic engineering,and the recombinant expression vector pET21a-Nb 2B3-PE38 was obtained and transformed into BL21(DE3)competent cells for expression purification and identification.The binding activity of Nb 2B3-PE38 to CD70 molecule was detected by indirect ELISA and FACS.The in vitro killing activity of Nb 2B3-PE38 against renal clear cell carcinoma(786-O)with high expression of CD70 molecule was detected by MTT assay.The effect of Nb 2B3-PE38 on the apoptosis of 786-O cells was identified by AnnexinⅤ-FITC/PI double staining.Results:The recombinant immunotoxin Nb 2B3-PE38 against CD70 nanobody was successfully constructed,and the recombinant protein with a purity higher than 90%was purified.The results of SDS-PAGE and WB showed that the target protein was correctly expressed and the molecular weight was 56000.The purified Nb 2B3-PE38 could specifically bind to the recombinant CD70 antigen and the CD70 molecule on the surface of 786-O cells.25μg/mL Nb 2B3-PE38 has a highly significant killing effect on 786-O cells(P<0.001),and promotes apoptosis of 786-O cells(P<0.01).Its killing effect was stronger than that of positive control cisplatin(P<0.01).Conclusion:The immunotoxin Nb 2B3-PE38,which specifically targets CD70 molecules,was successfully prepared.This immunotoxin can effectively kill 786-O cells and induce apoptosis.
作者 徐新兰 刘畅 张鑫 胡倩倩 李江伟 XU Xinlan;LIU Chang;ZHANG Xin;HU Qianqian;LI Jiangwei(Xinjiang Key Laboratory of Biological Resources and Genetic Engineering,College of Life Science and Technology,Xinjiang University,Urumqi 830046,Xinjiang,China)
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2023年第8期665-671,共7页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金(No.31570935)。
关键词 CD70 铜绿假单胞杆菌外毒素 纳米抗体 PE38 重组免疫毒素 肾透明细胞癌 786-O细胞 细胞毒性 靶向治疗 CD70 pseudomonas aeruginosa exotoxin nanoantibody PE38 recombinant immunotoxin renal clear cell carcinoma 786-O cell cytotoxicity targeted therapy
  • 相关文献

参考文献6

二级参考文献90

  • 1Hehlmann R,Hochhaus A,Baccarani M.Chronic myeloid leukaemia[J].Lancet,2007;370(9584):342-350.
  • 2Chomel J C,Turhan A G.Chronic myeloid leukemia stem cells in the era of targeted therapies:resistance,persistence and long-term dormancy[J].Oncotarget,2011;2(9):713-727.
  • 3Singh R,Zhang Y,Pastan I et al.Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy[J].Clin Cancer Res,2012;18(1):152-160.
  • 4Kreitman R J,Tallman M S,Robak T et al.Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox(CAT-8015 or HA22) in patients with hairy cell leukemia[J].J Clin Oncol,2012;30(15):1822-1828.
  • 5Wei H,Xiang L,Wayne A S et al.Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy[J].Proc Natl Acad Sci USA,2012;109(18):6898-6903.
  • 6Du X,Xiang L,Mackall C et al.Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL receptor 2 agonist antibody[J].Clin Cancer Res,2011;17(18):5926-5934.
  • 7Onda M,Beers R,Xiang L et al.Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes[J].Proc Natl Acad Sci USA,2011;108(14):5742-5747.
  • 8Luther N,Cheung N K,Souliopoulos E P et al.Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38[J].Mol Cancer Ther,2010;9(4):1039-1046.
  • 9Zhou X X,Ji F,Zhao J L et al.Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells[J].J Gastroenterol Hepatol,2010;25(7):1266-1275.
  • 10Lory S,Strom M S,Johnson K.Expression and secretion of the cloned Pseudomonas aeruginosa exotoxin A by Escherichia coli[J].J Bacteriol,1988;170(2):714-719.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部